Frontiers of Medicine in China

, Volume 4, Issue 2, pp 139–146 | Cite as

Review of hand, foot and mouth disease

Review

Abstract

Hand, foot and mouth disease (HFMD) is an acute viral illness that primarily affects infants and young children, and often occurs in clusters or outbreaks. The major causative agents of HFMD are coxsackievirus A16 (CVA16), human enterovirus 71 (HEV71) and coxsackievirus A10 (CVA10), of the genus Enterovirus in the family Picornaviridae. HFMD caused by EV71 is associated with severe neurological complications and death. Since the late 1990s, several major epidemics of EV71 HFMD have swept through the Asia-Pacific region, associated with a rapid fulminant course, severe neurological complications, and a large number of fatalities. Until now, little has been known about the genetics and transmission trends of the fast-mutation virus, and there is no effective and specific antiviral therapy or vaccine for HFMD. It is time to step up efforts to understand the molecular epidemics and pathogenesis so that we can develop effective management strategies and surveillance programs.

Keywords

hand foot and mouth disease epidemiology pathogenesis management surveillance 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Yan J J, Su I J, Chen P F, Liu C C, Yu C K, Wang J R. Complete genome analysis of enterovirus 71 isolated from an outbreak in Taiwan and rapid identification of enterovirus 71 and coxsackievirus A16 by RT-PCR. J Med Virol, 2001, 65(2): 331–339CrossRefPubMedGoogle Scholar
  2. 2.
    Bible J M, Pantelidis P, Chan P K, Tong C Y. Genetic evolution of enterovirus 71: epidemiological and pathological implications. Rev Med Virol, 2007, 17(6): 371–379CrossRefPubMedGoogle Scholar
  3. 3.
    Schmidt N J, Lennette E H, Ho H H. An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis, 1974, 129(3): 304–309PubMedGoogle Scholar
  4. 4.
    Deibel R, Gross L L, Collins D N. Isolation of a new enterovirus (38506). Proc Soc Exp Biol Med, 1975, 148(1): 203–207PubMedGoogle Scholar
  5. 5.
    Blomberg J, Lycke E, Ahlfors K, Johnsson T, Wolontis S, von Zeipel G. Letter: New enterovirus type associated with epidemic of aseptic meningitis and-or hand, foot, and mouth disease. Lancet, 1974, 2(7872): 112CrossRefPubMedGoogle Scholar
  6. 6.
    Tagaya I, Tachibana K. Epidemic of hand, foot and mouth disease in Japan, 1972–1973: difference in epidemiologic and virologic features from the previous one. Jpn J Med Sci Biol, 1975, 28(4): 231–234PubMedGoogle Scholar
  7. 7.
    Gilbert G L, Dickson K E, Waters M J, Kennett M L, Land S A, Sneddon M. Outbreak of enterovirus 71 infection in Victoria, Australia, with a high incidence of neurologic involvement. Pediatr Infect Dis J, 1988, 7(7): 484–488CrossRefPubMedGoogle Scholar
  8. 8.
    Shindarov L M, Chumakov M P, Voroshilova M K, Bojinov S, Vasilenko S M, Iordanov I, Kirov I D, Kamenov E, Leshchinskaya E V, Mitov G, Robinson I A, Sivchev S, Staikov S. Epidemiological, clinical, and pathomorphological characteristics of epidemic poliomyelitis-like disease caused by enterovirus 71. J Hyg Epidemiol Microbiol Immunol, 1979, 23(3): 284–295PubMedGoogle Scholar
  9. 9.
    Nagy G, Takatsy S, Kukan E, Mihaly I, Domok I. Virological diagnosis of enterovirus type 71 infections: experiences gained during an epidemic of acute CNS diseases in Hungary in 1978. Arch Virol, 1982, 71(3): 217–227CrossRefPubMedGoogle Scholar
  10. 10.
    World Health Organization. Outbreak of hand, foot and mouth disease in Sarawak. Cluster of deaths among infants and young children. Wkly Epidemiol Rec, 1997, 72(28): 211–212Google Scholar
  11. 11.
    Lin T Y, Chang L Y, Hsia S H, Huang Y C, Chiu C H, Hsueh C, Shih S R, Liu C C, Wu M H. The 1998 enterovirus 71 outbreak in Taiwan: pathogenesis and management. Clin Infect Dis, 2002, 34 Suppl 2: S52–57CrossRefPubMedGoogle Scholar
  12. 12.
    Shimizu H, Utama A, Onnimala N, Li C, Li-Bi Z, Yu-Jie M, Pongsuwanna Y, Miyamura T. Molecular epidemiology of enterovirus 71 infection in the Western Pacific Region. Pediatr Int, 2004, 46(2): 231–235CrossRefPubMedGoogle Scholar
  13. 13.
    AbuBakar S, Chee H Y, Al-Kobaisi M F, Xiaoshan J, Chua K B, Lam S K. Identification of enterovirus 71 isolates from an outbreak of hand, foot and mouth disease (HFMD) with fatal cases of encephalomyelitis in Malaysia. Virus Res, 1999, 61(1): 1–9CrossRefPubMedGoogle Scholar
  14. 14.
    Lum L C, Wong K T, Lam S K, Chua K B, Goh A Y, Lim W L, Ong B B, Paul G, AbuBakar S, Lambert M. Fatal enterovirus 71 encephalomyelitis, J Pediatr, 1998, 133(6): 795–798CrossRefPubMedGoogle Scholar
  15. 15.
    Qiu J. Viral outbreak in China tests government efforts. Nature, 2009, 458(7238): 554–555CrossRefPubMedGoogle Scholar
  16. 16.
    Li L, He Y, Yang H, Zhu J, Xu X, Dong J, Zhu Y, Jin Q. Genetic characteristics of human enterovirus 71 and coxsackievirus A16 circulating from 1999 to 2004 in Shenzhen, People’s Republic of China. J Clin Microbiol, 2005, 43(8): 3835–3839CrossRefPubMedGoogle Scholar
  17. 17.
    Yang F, Ren L, Xiong Z, Li J, Xiao Y, Zhao R, He Y, Bu G, Zhou S, Wang J, Qi J. Enterovirus 71 outbreak in the People’s Republic of China in 2008. J Clin Microbiol, 2009, 47(7): 2351–2352CrossRefPubMedGoogle Scholar
  18. 18.
  19. 19.
  20. 20.
    Brown B A, Oberste M S, Alexander J P Jr, Kennett M L, Pallansch M A. Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J Virol, 1999, 73(12): 9969–9975PubMedGoogle Scholar
  21. 21.
    McMinn P, Lindsay K, Perera D, Chan H M, Chan K P, Cardosa M J. Phylogenetic analysis of enterovirus 71 strains isolated during linked epidemics in Malaysia, Singapore, and Western Australia. J Virol, 2001, 75(16): 7732–7738CrossRefPubMedGoogle Scholar
  22. 22.
    Tong C, Bible J. Global epidemiology of Enterovirus 71. Future Virol, 2009, 4(5): 501–510CrossRefGoogle Scholar
  23. 23.
    Zhang Y, Tan X J, Wang H Y, Yan D M, Zhu S L, Wang D Y, Ji F, Wang X J, Gao Y J, Chen L, An H Q, Li D X, Wang S W, Xu A Q, Wang Z J, Xu W B. An outbreak of hand, foot, and mouth disease associated with subgenotype C4 of human enterovirus 71 in Shandong, China. J Clin Virol, 2009, 44(4): 262–267CrossRefPubMedGoogle Scholar
  24. 24.
    Huang S C, Hsu Y W, Wang H C, Huang S W, Kiang D, Tsai H P, Wang S M, Liu C C, Lin K H, Su I J, Wang J R. Appearance of intratypic recombination of enterovirus 71 in Taiwan from 2002 to 2005. Virus Res, 2008, 131(2): 250–259CrossRefPubMedGoogle Scholar
  25. 25.
    Yoke-Fun C, AbuBakar S. Phylogenetic evidence for inter-typic recombination in the emergence of human enterovirus 71 subgenotypes. BMC Microbiol, 2006, 6: 74CrossRefPubMedGoogle Scholar
  26. 26.
    Ding N Z, Wang X M, Sun S W, Song Q, Li S N, He C Q. Appearance of mosaic enterovirus 71 in the 2008 outbreak of China. Virus Res, 2009, 145(1): 157–161CrossRefPubMedGoogle Scholar
  27. 27.
    Ho H Y, Cheng M L, Weng S F, Chang L, Yeh T T, Shih S R, Chiu D T. Glucose-6-phosphate dehydrogenase deficiency enhances enterovirus 71 infection. J Gen Virol, 2008, 89(Pt 9): 2080–2089CrossRefPubMedGoogle Scholar
  28. 28.
    Chang L Y, Chang I S, Chen W J, Huang Y C, Chen G W, Shih S R, Juang J L, Shih H M, Hsiung C A, Lin T Y, Huang L M. HLA-A33 is associated with susceptibility to enterovirus 71 infection. Pediatrics, 2008, 122(6): 1271–1276CrossRefPubMedGoogle Scholar
  29. 29.
    Huemer H P, Ortner B, Huang C W, Schmid D, Mutz I, Wewalka G, Yang J Y, Allerberger F. Isolating Asian enterovirus 71 subgenogroup C4 in two Austrian clinical samples from 2004. Euro Surveill, 2008, 13(28): pii: 18922Google Scholar
  30. 30.
    Zhang Y, Tan X J, Wang H Y, Yan D M, Zhu S L, Wang D Y, Ji F, Wang X J, Gao Y J, Chen L, An H Q, Li D X, Wang S W, Xu A Q, Wang Z J, Xu W B. An outbreak of hand, foot, and mouth disease associated with subgenotype C4 of human enterovirus 71 in Shandong, China. J Clin Virol, 2009, 44(4): 262–267CrossRefPubMedGoogle Scholar
  31. 31.
    Qiu J. Enterovirus 71 infection: a new threat to global public health? Lancet Neurol, 2008, 7(10): 868–869CrossRefPubMedGoogle Scholar
  32. 32.
    Chen L C, Shyu H W, Chen S H, Lei H Y, Yu C K, Yeh T M. Enterovirus 71 infection induces Fas ligand expression and apoptosis of Jurkat cells. J Med Virol, 2006, 78(6): 780–786CrossRefPubMedGoogle Scholar
  33. 33.
    Chang S C, Lin J Y, Lo L Y, Li M L, Shih S R. Diverse apoptotic pathways in enterovirus 71-infected cells. J Neurovirol, 2004, 10(6): 338–349CrossRefPubMedGoogle Scholar
  34. 34.
    Yamayoshi S, Yamashita Y, Li J, Hanagata N, Minowa T, Takemura T, Koike S. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med, 2009, 15(7): 798–801CrossRefPubMedGoogle Scholar
  35. 35.
    Nishimura Y, Shimojima M, Tano Y, Miyamura T, Wakita T, Shimizu H. Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat Med, 2009, 15(7): 794–797CrossRefPubMedGoogle Scholar
  36. 36.
    Lin T Y, Chang L Y, Hsia S H, Huang Y C, Chiu C H, Hsueh C, Shih S R, Liu C C, Wu M H. The 1998 enterovirus 71 outbreak in Taiwan: pathogenesis and management. Clin Infect Dis, 2002, 34(Suppl 2): S52–57CrossRefPubMedGoogle Scholar
  37. 37.
    Chang L Y, Hsia S H, Wu C T, Huang Y C, Lin K L, Fang T Y, Lin T Y. Outcome of enterovirus 71 infections with or without stagebased management: 1998 to 2002. Pediatr Infect Dis J, 2004, 23(4): 327–332CrossRefPubMedGoogle Scholar
  38. 38.
    Chang LY, Lin T Y, Hsu K H, Huang Y C, Lin K L, Hsueh C, Shih S R, Ning H C, Hwang M S, Wang H S, Lee C Y. Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. Lancet, 1999; 354(9191): 1682–1686CrossRefPubMedGoogle Scholar
  39. 39.
    Wang S M, Lei H Y, Huang M C, Su L Y, Lin H C, Yu C K, Wang J L, Liu C C. Modulation of cytokine production by intravenous immunoglobulin in patients with enterovirus 71-associated brainstem encephalitis. J Clin Virol, 2006, 37(1): 47–52CrossRefPubMedGoogle Scholar
  40. 40.
    Wang S M, Lei H Y, Huang M C, Wu J M, Chen C T, Wang J N, Wang J R, Liu C C. Therapeutic efficacy of milrinone in the management of enterovirus 71-induced pulmonary edema. Pediatr Pulmonol, 2005, 39(3): 219–223CrossRefPubMedGoogle Scholar
  41. 41.
    Chang L Y. Enterovirus 71 in Taiwan. Pediatr Neonatol, 2008, 49 (4): 103–112CrossRefPubMedGoogle Scholar
  42. 42.
    Chen T C, Weng K F, Chang S C, Lin J Y, Huang P N, Shih S R. Development of antiviral agents for enteroviruses. J Antimicrob Chemother, 2008, 62(6): 1169–1173CrossRefPubMedGoogle Scholar
  43. 43.
    Pevear D C, Tull T M, Seipel M E, Groarke J M. Activity of pleconaril against enteroviruses. Antimicrob Agents Chemother, 1999, 43(9): 2109–2115PubMedGoogle Scholar
  44. 44.
    Shia K S, Li W T, Chang C M, Hsu M C, Chern J H, Leong M K, Tseng S N, Lee C C, Lee Y C, Chen S J, Peng K C, Tseng H Y, Chang Y L, Tai C L, Shih S R. Design, synthesis, and structureactivity relationship of pyridyl imidazolidinones: a novel class of potent and selective human enterovirus 71 inhibitors. J Med Chem, 2002, 45(8): 1644–1655CrossRefPubMedGoogle Scholar
  45. 45.
    Li Z H, Li C M, Ling P, Shen F H, Chen S H, Liu C C, Yu C K. Ribavirin reduces mortality in enterovirus 71-infected mice by decreasing viral replication. J Infect Dis, 2008, 197(6): 854–857CrossRefPubMedGoogle Scholar
  46. 46.
    Foo D G, Alonso S, Phoon M C, Ramachandran N P, Chow V T, Poh C L. Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides. Virus Res, 2007, 125(1): 61–68CrossRefPubMedGoogle Scholar
  47. 47.
    Chen H L, Huang J Y, Chu T W, Tsai T C, Hung C M, Lin C C, Liu F C, Wang L C, Chen Y J, Lin M F, Chen C M. Expression of VP1 protein in the milk of transgenic mice: a potential oral vaccine protects against enterovirus 71 infection. Vaccine, 2008, 26(23): 2882–2889CrossRefPubMedGoogle Scholar
  48. 48.
    Ooi M H, Solomon T, Podin Y, Mohan A, Akin W, Yusuf M A, del Sel S, Kontol K M, Lai B F, Clear D, Chieng C H, Blake E, Perera D, Wong S C, Cardosa J. Evaluation of different clinical sample types in diagnosis of human enterovirus 71-associated hand-footand-mouth disease. J Clin Microbiol, 2007, 45(6): 1858–1866CrossRefPubMedGoogle Scholar
  49. 49.
    Perez-Velez C M, Anderson M S, Robinson C C, McFarland E J, Nix W A, Pallansch M A, Oberste M S, Glode M P. Outbreak of neurologic enterovirus type 71 disease: a diagnostic challenge. Clin Infect Dis, 2007, 45(8): 950–957CrossRefPubMedGoogle Scholar
  50. 50.
    Ooi M H, Wong S C, Mohan A, Podin Y, Perera D, Clear D, del Sel S, Chieng C H, Tio P H, Cardosa M J, Solomon T. Identification and validation of clinical predictors for the risk of neurological involvement in children with hand, foot, and mouth disease in Sarawak. BMC Infect Dis, 2009, 9: 3CrossRefPubMedGoogle Scholar
  51. 51.
    Chen K T, Chang H L, Wang S T, Cheng Y T, Yang J Y. Epidemiologic features of hand-foot-mouth disease and herpangina caused by enterovirus 71 in Taiwan, 1998–2005. Pediatrics, 2007, 120(2): e244–252CrossRefPubMedGoogle Scholar
  52. 52.
    Podin Y, Gias E L, Ong F, Leong Y W, Yee S F, Yusof M A, Perera D, Teo B, Wee T Y, Yao S C, Yao S K, Kiyu A, Arif M T, Cardosa M J. Sentinel surveillance for human enterovirus 71 in Sarawak, Malaysia: lessons from the first 7 years. BMC Public Health, 2006, 6: 180CrossRefPubMedGoogle Scholar
  53. 53.
    Chen S C, Chang H L, Yan T R, Cheng Y T, Chen K T. An eight-year study of epidemiologic features of enterovirus 71 infection in Taiwan. Am J Trop Med Hyg, 2007, 77(1): 188–191PubMedGoogle Scholar

Copyright information

© Higher Education Press and Springer-Verlag Berlin Heidelberg 2010

Authors and Affiliations

  1. 1.State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of MedicineZhejiang UniversityHangzhouChina

Personalised recommendations